South & Central America Nerve Repair & Regeneration Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis – by Product (Neurostimulation & Neuromodulation Devices {Internal Neurostimulation Devices [Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation] and External Neurostimulation Devices [Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, Respiratory Electrical Stimulation Devices]} and Biomaterials), and Application (Neurostimulation & Neuromodulation Applications {Internal neurostimulation & neuromodulation, and External neurostimulation & neuromodulation}, and Nerve Repair & Regeneration Applications {Direct Nerve Repair/Neurorrhaphy [Epineural Repair, Perineural Repair, and Group Fascicular Repair], Nerve Grafting [Autografts, Allografts, and Xenografts], and Stem cell therapy})

No. of Pages: 181
Report Code: BMIRE00027559
Category: Life Sciences
South & Central America Nerve Repair & Regeneration Market
Buy Now

The nerve repair & regeneration market in South & Central America is expected to grow from US$ 343.17 million in 2022 to US$ 583.16 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2022 to 2028.

Advancements in Stem Cell Therapy for Nerve Repair & Regeneration to Bolster Nerve Repair & Regeneration Market Growth in South & Central America during Forecast Period

Cell-based therapy improves the functional clinical outcome after nerve injury. In recent years, the technology in constructing tissue-engineered nerve grafts has seen significant progress. Incorporating stem cells such as embryonic stem cells, neural stem cells, bone marrow mesenchymal stem cells, adipose stem cells, skin-derived precursor stem cells, and induced pluripotent stem cells have enhanced the therapeutic effects of tissue-engineered nerve grafts. The high effectiveness of stem cells enlightens the optimistic future of the large-scale clinical use of stem cells. Incorporating stem cells as seed cells into the biomaterial-based scaffolds increases the effectiveness of tissue-engineered nerve grafts and boosts the regenerative process. Numerous stem cells such as neural stem cells, embryonic stem cells, adipose stem cells, skin-derived precursor stem cells, induced pluripotent stem cells, and bone marrow mesenchymal stem cells have been used in neural tissue engineering. Cell-based therapy improves neural regeneration after peripheral nerve injuries (PNIs); it has introduced a new perspective to regenerative medicine. The main mechanisms that highlight the valuable effects of stem cells on neural regeneration are augmenting axonal regeneration, remyelination, and muscle mass preservation. Thus, the advancements in stem cell therapy for nerve repair & regeneration are likely to offer growth opportunities for the nerve repair & regeneration market players operating in South & Central America.

Market Overview

The South & Central America nerve repair & regeneration market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil accounted for a significant share of the market in 2021, followed by Argentina. The nerve repair & regeneration market in South & Central America is expected to grow due to the rising cases of Parkinson’s and Alzheimer’s diseases, a surge in the geriatric population, and a rising number of developments by various organizations in countries across the region.

South & Central America Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)South & Central America Nerve Repair & Regeneration Market Segmentation 

The South & Central America nerve repair & regeneration market is bifurcated on the basis of product and application.

  • Based on product, the South & Central America nerve repair & regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment accounted for a larger market share in 2022.
  • Based on application, the South & Central America nerve repair & regeneration market is bifurcated into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held a larger market share in 2022. 
  • Based on country, the South & Central America nerve repair & regeneration market is segmented into Brazil, Argentina, and the Rest of South & Central America. Further, Brazil dominated the market in 2022.

Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in South & Central America.  

South & Central America Nerve Repair & Regeneration Market Strategic Insights

global-market-strategic-framework
Get more information on this report

South & Central America Nerve Repair & Regeneration Market Segmentation Analysis

South & Central America Nerve Repair & Regeneration Market Report Highlights

South & Central America Nerve Repair & Regeneration Report Scope

Report Attribute Details
Market size in 2022 US$ 343.17 Million
Market Size by 2028 US$ 583.16 Million
CAGR (2022 - 2028) 9.2%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Product
  • Neurostimulation & Neuromodulation Devices
  • Biomaterials
By Application
  • Neurostimulation & Neuromodulation Applications
  • Nerve Repair & Regeneration Applications
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Axogen Corporation
  • Boston Scientific Corporation
  • Integra LifeSciences
  • Medtronic
  • Abbott Laboratories
  • Stryker Corporation
  • Neuronetics
  • LivaNova PLC
  • Baxter
  • Polyganics BV
Get more information on this report

South & Central America Nerve Repair & Regeneration Market Country and Regional Insights

south-and-central-america-nerve-repair-and-regeneration-market
Get more information on this report

The List of Companies - South & Central America Nerve Repair & Regeneration Market

  1. Axogen Corporation
  2. Boston Scientific Corporation      
  3. Integra LifeSciences
  4. Medtronic
  5. Abbott Laboratories
  6. Stryker Corporation
  7. Neuronetics
  8. LivaNova PLC
  9. Baxter
  10. Polyganics BV
Frequently Asked Questions
How big is the South & Central America Nerve Repair & Regeneration Market?

The South & Central America Nerve Repair & Regeneration Market is valued at US$ 343.17 Million in 2022, it is projected to reach US$ 583.16 Million by 2028.

What is the CAGR for South & Central America Nerve Repair & Regeneration Market by (2022 - 2028)?

As per our report South & Central America Nerve Repair & Regeneration Market, the market size is valued at US$ 343.17 Million in 2022, projecting it to reach US$ 583.16 Million by 2028. This translates to a CAGR of approximately 9.2% during the forecast period.

What segments are covered in this report?

The South & Central America Nerve Repair & Regeneration Market report typically cover these key segments-

  • Product (Neurostimulation & Neuromodulation Devices, Biomaterials)
  • Application (Neurostimulation & Neuromodulation Applications, Nerve Repair & Regeneration Applications)

What is the historic period, base year, and forecast period taken for South & Central America Nerve Repair & Regeneration Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Nerve Repair & Regeneration Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in South & Central America Nerve Repair & Regeneration Market?

    The South & Central America Nerve Repair & Regeneration Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Axogen Corporation
  • Boston Scientific Corporation
  • Integra LifeSciences
  • Medtronic
  • Abbott Laboratories
  • Stryker Corporation
  • Neuronetics
  • LivaNova PLC
  • Baxter
  • Polyganics BV
  • Who should buy this report?

    The South & Central America Nerve Repair & Regeneration Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Nerve Repair & Regeneration Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now

    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)